2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3328
  



  

  
Submitter : 
  

  
Mrs. Roslyn Stephen
  

  
Date & Time: 
  

  
12/15/2006 08:12:24
  



  

  
Organization : 
  

  
Mrs. Roslyn Stephen
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Please issue guidelines to restrict pharmaceutical companies to the use of non-fetal stem cell lines only in the manufacture of vaccines.  It is my belief that there is an abundance of such ethical stem cell lines for this purpose and it is thus not necessary to use fetal stem cells.